Sasha Latypova
Merit
 3049
Writer at Trial Site News | mRNA Fraud - Regulatory and Manufacturing Investigations
-Ex-pharma/biotech with 25 years of experience in clinical trials, clinical technologies and regulatory approvals. Owned and managed several contract research organizations and worked for 60+ pharma companies worldwide. Interacted with FDA as part of scientific industry consortium on improving cardiac safety assessments in clinical trials.
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2024 - Trial Site News